South Korea vs Oman: Previously treated cases tested for RR-/MDR-TB
South Korea
100.0%
in 2024
Oman
100.0%
in 2024
South Korea rank
1st
Oman rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- South Korea
- Oman
How they compare
South Korea currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
Across all 12 years both countries report, Oman has been ahead every year.
South Korea ranks 1st and Oman ranks 1st of 180 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Korea | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.5% | 97.5% | 42.0% | Oman |
| 2020s | 97.0% | 100.0% | 3.0% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, South Korea or Oman?
- South Korea, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between South Korea and Oman?
- 0.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Oman?
- 12 years are reported by both, from 2011 to 2024.
- How do South Korea and Oman rank globally for previously treated cases tested for rr-/mdr-tb?
- South Korea ranks 1st and Oman ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.